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Objective: To verify the adequacy of red blood cell (RBC) prescription to pediatric 
patients in different sectors of a pediatric hospital. 
Method: A retrospective study was conducted including 837/990 RBC transfusion 
requisition forms for children and adolescents (0 to 13 years old) filed in between 
January 2007 and April 2015 by the pediatricians of the emergency room (ER), 
infirmary ward and intensive care unit (pICU). Transfusion requisition forms 
belonging to patients with chronic anemia or acute hemorrhage, as well as 
incompletes requisition forms, were excluded. 
Results: Trigger, prescribed volume and subtype of RBC concentrates were adequate 
in 532 (65.3%), 460 (58.8%) and 805 (96.2%) of the transfusions, respectively. When 
the clinical picture was considered, prescription adequacy was higher compared 
to the use of the hemoglobin level alone (70.9% vs. 41%). The pICU had the high-
est correct trigger percentage (343 [71.6%]; p<0.001) while the ER showed more 
often adequate prescribed volumes (119 [66.1%]; p=0.020). The most common 
inadequacy regarding volume was that of prescriptions above the recommenda-
tion > 15 mL/kg found in 309 cases (36.9%). Thirty-two (32) RBC subtypes were 
requested and none were consistent with current recommendations. 
Conclusion: The results obtained in our study showed that RBC transfusion 
occurred more appropriately when the clinical picture was taken into account 
at request. There was a tendency to prescribe higher volumes and RBC subtypes 
without the justification of current protocols. Hemotherapic teachings at un-
dergraduate level and medical residency must be improved.
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introduction
Performed since the 17th century, blood transfusion en-
tered its scientific era in 1901 with the discovery of the 
ABO blood system by Karl Landsteiner.1 Initially, the goal 
of transfusions was to maintain a hemoglobin (Hb) level 
greater than or equal to 10 g/dL.2 Later, especially in the 
last two decades, publications have shown safety and 
superior results with lower triggers. Normovolemic pa-
tients were shown to tolerate Hb concentrations between 
5 and 6 g/dL.3 Regardless of the cause of anemia (de-
creased production of red blood cells, hemolysis or bleed-
ing),4 the goal of transfusion is to normalize the transport 
of oxygen2 and, therefore, the transfusion trigger has 
different values in different situations, ranging from Hb 
7 g/dL in clinically stable children,5-8 with acute bleed-
ing9 and sepsis but no shock;10 to 7-8 g/dL in the post-
surgical period,11-14 and 10 g/dL in case of severe sepsis 
or septic shock.15,16 
Despite this knowledge, several services still adopt 
different transfusion protocols even for patients in simi-
lar clinical contexts, so that higher triggers relate to a 
greater frequency of transfusion reactions.3,7,8,17,18
Transfusion is a mortality risk factor in critically ill 
children19 and may cause immune and non immune-me-
diated reactions including, more frequently: febrile non-
hemolytic transfusion reaction, hemolytic reaction, alergies, 
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volume overload and infections.1,2,5,20 Microcirculatory 
changes can also occur,5,21 as well as increased incidence of 
cancers.22 Reactions may occur in 0.95%23 to 3.8% of cases.24
Calculation of the correct volume is also important, 
since low volume results in less than ideal yield and high 
volume is associated with risk of circulatory overload. This 
is one of the most common transfusion reactions, with a 
mortality rate of 12%.20 In children with acute anemia and 
normovolemia, a volume of transfused red blood cells (RBC) 
concentrates between 1025-27 and 1525 mL/kg is indicated. 
An appropriate choice of RBC subtype (filtered, ir-
radiated, washed and phenotyped) influences the transfu-
sion yield and causes fewer transfusion reactions in spe-
cific contexts.2,25 Filtered RBC has 99% of its neutrophils 
removed and is indicated mainly to avoid febrile non-
hemolytic reaction in polytransfusion and the transmis-
sion of cytomegalovirus in immunosuppressed patients.25 
RBC concentrates irradiated at 25 gray prevents clonal 
proliferation of donor lymphocytes in the immunode-
pressed recipient, thereby avoiding transfusional graft 
versus host disease.25 Washed RBCs have the highest pos-
sible amount of their plasma replaced with 0.9% saline 
solution in order to remove plasma proteins that may 
cause anaphylactic reaction in individuals with congeni-
tal deficiency of some serum protein (immunoglobulin 
A, haptoglobin and ferritin) or who already presented a 
severe allergic reaction to the previous transfusion.25 Phe-
notyped RBC is transfused to patients that required ex-
tended compatibility research between donor and re-
cipient, in addition to ABO and Rh blood groups (kell, 
Duffy, Kidd and MNS). In pediatrics, this phenotyping 
procedure is carried out mainly in the poly-transfused to 
avoid erythrocyte alloimmunization.25
There are few studies evaluating the adequacy of RBC 
prescription in pediatrics7,9,14, and those available in the 
literature evaluated the trigger, but not the volume and 
subtype indicated.
The objective of our study was to evaluate the trans-
fusional trigger, the prescribed volume and the choice of 
red blood cell subtypes in children admitted into a pub-
lic hospital and compare with current recommendations 
in the literature.
Method
A retrospective study carried out at Hospital e Pronto-
-Socorro Central de São Bernardo do Campo, in the Great-
er São Paulo area, Brazil. We reviewed the transfusion 
requisition forms for children and adolescents from 0 to 
13 years of age, filled out by pediatricians from three sec-
tors: Emergency room (ER), the infirmary ward and the 
pediatric intensive care unit (pICU) from January 2007 
to April 2015.
During the study period, the pediatrics consisted of 
four beds in the emergency room, five in the observation 
room, 40 in the infirmary ward, and five pICU beds. The 
hospital did not include an obstetrical center, a nursery, 
a surgical center or oncology/hematology service. It did 
have a transfusion agency that stored some blood com-
ponents and performed simple tests such as ABO and Rh 
blood typing, and direct and reverse cross-tests. When-
ever a subtype of blood component was requested and 
the transfusion agency did not have it, the request was 
sent to the head office in the city of São Paulo. The sup-
plied RBC preservative solution was CPDA-1 (citrate, 
phosphate, dextrose and adenine).
Of the 990 RBC transfusions performed during the 
study period, 837 were included in the series. In all, 94 
and 59 transfusion requests were excluded because they 
were made for patients with chronic anemia (81-sickle 
cell disease, 11-bone marrow aplasia, 1-hemoglobinopathy 
C and 1-spherocytosis) and acute hemorrhage, respectively, 
on account of trigger variability in these two conditions and 
the absence of information in the form, which are essential 
for assessing adequacy. Later, we excluded 23 other re-
quests from the transfusion trigger analysis and 55 from 
the prescribed volume analysis, as Hb value and the pa-
tient’s weight, respectively, were not recorded.
In order to assess the adequacy of the transfusional 
trigger, prescribed volume and choice of RBC subtypes, 
we used the 2015 recommendations of the Brazilian Min-
istry of Health.25 However, these guidelines do not discuss 
some of the situations found in our study. Therefore, to 
analyze the transfusion trigger in children older than 4 
months, with acute normovolemic anemia but otherwise 
stable, we used the 2012 recommendations of the Amer-
ican Association of Blood Banks (7 g/dL).6 To analyze the 
trigger in cases of septic shock, we used the recommenda-
tions of the American Heart Association – Pediatric Ad-
vanced Life Support (10 g/dL).27
Data collected from the transfusion requisition forms:
 • General: age (months), gender, presence of underlying 
conditions and origin of the transfusion request form 
(ER, infirmary ward or pICU).
 • Transfusion characteristics:
 — Trigger (reason and justification for transfu-
sion): evaluated whether it was based solely on 
Hb value or clinical-laboratory correlation. All 
transfusions performed in patients with Hb le-
vels below 7 g/dL were considered adequate. Re-
quests for patients with Hb greater than or equal 
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to 7 g/dL were evaluated individually, taking 
into account the clinical reason, the presence of 
underlying disease and if there was hemodyna-
mic decompensation. 
 — Volume prescribed: Volumes between 10 and 
15 mL/kg were considered adequate.
 — RBC subtype: the request for filtered, irradiated, 
washed or phenotyped components was evalua-
ted, considering the presence of underlying disea-
se and the patient’s history.
The study was approved by the Research Ethics 
Committee of Faculdade de Medicina do ABC (Opinion 
no. 1.402.884). 
The data were typed and consolidated into an Excel 
(Microsoft) worksheet and analyzed using SPSS 24.0 
statistical program. Qualitative variables were described 
in the form of absolute numbers and percentages. Con-
tinuous variables were analyzed for their distribution and 
presented as mean ± standard deviation. To compare the 
qualitative data we used the Chi-square test. The confi-
dence level was 5%.
results
In our sample, the male gender predominated (471 [56.3%]), 
the mean age was 23.3 ± 8 months and the median was 
8 months; 504 (60.2%) of the transfusions were performed 
in children less than 12 months old and the most com-
mon clinical contexts were hemodynamic and respira-
tory changes (Table 1). Regarding the origin of the trans-
fusion request, 201 (24%) were made in the ER, 148 (17.7%) 
in the infirmary ward and 488 (58.3%) in the pICU (Table 
1). A greater percentage of transfusions in patients older 
than 12 months were performed in the pICU compared 
to the ER and the infirmary ward (329 [65.2%] vs. 75 
[14.9%] vs. 100 [19.8%], p<0.001). There was no difference 
between the places of origin of the transfusion request 
in relation to gender (p=0.441) and presence of underly-
ing diseases (p=0.061). 
The most common inadequacy, in relation to volume, 
was prescription above the recommendation (> 15 mL/kg; 
309 [36.9%]) (Table 1). Mean Hb and mean prescribed 
volume were 8.3 ± 1.5 g/dL (range: 2.6 to 16.1 g/dL) and 
15.2 ± 4.3 mL/kg (range: 4.9 to 57.1 mL/kg), respectively. 
The clinical status was considered in 682 (81.5%) of 
transfusions (Table 1). There were 663 transfusions with a 
description of the clinical context that caused it (Table 1). 
Trigger, prescribed volume and subtype of red cell 
concentrate were adequate in 532 (65.3%); 460 (58.8%) 
and 805 (96.2%) of transfusions, respectively (Table 2). 
TABLE 1 General characteristics for the  
transfusions performed.
Variable N %
Gender Male 471 56.3
Female 366 43.7
Age < 1 year 504 60.2
1 to 2 years 123 14.7
2 to 5 years 108 12.9
5 to 10 years 74 8.8
> 10 years 28 3.3
Clinical status Septic shock 287 34.3
Acute respiratory failure 124 14.8
Pneumonia 117 14
Hemodynamic decompensation 55 6.6
Mechanical ventilation 32 3.8
Other 48 5.7
Not described 174 20.8
Underlying disease Congenital heart disease 38 4.5
NPCE 18 2.2
Nephrotic syndrome 10 1.2
Other 29 3.5
No underlying disease 742 88.6
Origin ER 201 24.0
Infirmary 148 17.7
pICU 488 58.3
Reason Clinical 14 1.7
Laboratorial 155 18.5
Both 668 79.8
Pre-transfusion Hb < 7 g/dL 125 14.9
7 to 10 g/dL 582 69.5
> 10 g/dL 107 12.8
Lack of Hb record 23 2.7
Volume < 10 mL/kg/day 13 1.5
10 to 15 mL/kg/day 460 55
> 15 mL/kg/day 309 36.9
Lack of weight record 55 6.6
Subtype Plain RBC 805 96.2





*In some RBC concentrates there was a request for more than one subtype, so the sum of filtered, 
irradiated and washed is greater than the number of RBC packs with subtypes. ER: emergency 
room; NPCE: non-progressive chronic encephalopathy; Hb: hemoglobin; pICU: pediatric intensive 
care unit; RBC: red blood cells.
Among the clinical contexts that led to the indication 
of transfusion, there was a high adequacy in critically-ill 
children (94.5%, hemodynamic decompensation; 92.7%, 
acute respiratory failure; 87.5%, mechanical ventilation; 
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83.6%, septic shock). However, the adequacy was lower in 
children with non-severe conditions at the time of trans-
fusion, such as pneumonia without respiratory failure or 
mechanical ventilation, with only 12% (Table 2).
pICU had the highest correct trigger percentage (343 
[71.6%]; p<0.001), whereas ER had the prescribed volume 
right more often (119 [66.1%]; p=0.020) (Table 3) compared 
to the other groups.
There were 32 RBCs with subtype (3.8% of the total), 
15 RBCs with only one subtype of red cells and 17 com-
bining 2 or 3 subtypes. There was no difference between 
the sites of origin in relation to the subtype of red blood 
cells requested (Table 3).
discussion
Our study identified that, among red blood cell transfu-
sions performed, 1 in 3 and 41% were not in accordance 
with the current recommendations for indication and 
volume calculation, respectively. It should be emphasized 
that in none of the cases the use of specific subtypes of 
RBC would be indicated.  
TABLE 2 Adequacy of red blood cell transfusion.


















Trigger (n=814) Adequate 532 65.3
Reason (n=814) Clinical picture 
was considered
470 70.9
Hb only 62 41
Pre-transfusion Hb
(n=814)
< 7 g/dL 125 100
7 to 10 g/dL 391 67.2











Hb: hemoglobin; RBC: red blood cells.
TABLE 3 Comparison of the trigger, volume and subtype 
adequacy in relation to the site where red blood cell 
transfusion was performed.
ER Infirmary pICU p-value





















*Chi-square test significance level.
ER: emergency room; pICU: pediatric intensive care unit. 
There was no difference between the male and female 
gender regarding the adequacy of the trigger, volume and 
subtype of the red blood cell concentrate. More than half 
of the transfusions occurred in children less than 1 year 
of age, data similar to those observed in a publication 
that included a similar population.28
In the trigger analysis, there was inadequacy mainly 
in transfusions based only on Hb values, without consid-
ering the clinical picture, with pre transfusion Hb ≥ 10 g/dL, 
performed in the infirmary ward and in patients with 
respiratory disease without respiratory failure or me-
chanical ventilation. The largest study ever published 
with a pediatric population has shown that the prescrip-
tion of red blood cells based on current recommendations 
decreases the number of transfused RBCs by 44%.7 How-
ever, the study included exclusively children hospitalized 
in the pICU and thus in a clinical scenario different from 
ours with more stable children.
With respect to the prescribed volume, attention was 
drawn to the request for volumes above the recommend-
ed level, which increases the risk of transfusion-related 
circulatory overload. This transfusion reaction is one of 
the most frequent, with a growing incidence in the past 
years and mortality of 12%.20
The prescription of a specific subtype of RBCs leads 
to a longer waiting time for RBC concentrates, which may 
influence the prognosis of an unstable patient. After 
analyzing the requisitions, no clear justification for pre-
scribing these components was found.
The ER did not document the value of Hb in 6.5% of 
the transfusion requests, a fact that can be partly explained 
by the greater instability of the patients. The infirmary 
ward failed to record the weight in 1 out of 10 request forms. 
This fact may increase the risk of inadequacy of the pre-
scribed volume. Failure to record the weight and/or type 
of Hb makes it impossible for the transfusion agency to 
detect if there is any indication or calculation error and 
thus act to improve the transfusion practice of the service.
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Some hypotheses may be considered to justify the 
results obtained in our study. First, non-frequent updating 
of non-hematologic health professionals about proposed 
transfusion guidelines; second, the limited time available 
to address this issue in the medical undergraduate course 
and pediatric residency; and finally, the shortage of insti-
tutional continuing education programs on transfusion 
of blood components for the pediatric population. 
Standardization of transfusion procedures according 
to current literature can reduce the cost of hospitalization, 
avoid waste of blood components and, especially, reduce 
the number of transfusion reactions.29
The implementation of continuing education in 
transfusion medicine should be emphasized at all levels 
(undergraduate, medical residency and professional) 
minimizing potential harm to the pediatric patient and 
the health care system. Emphasis should be given to the 
teaching of transfusion medicine in medical school and 
medical residency settings by both professor and precep-
tor, in addition to the updating of professionals by fa-
cilitating the provision of continuing education materi-
als and courses, which could be done by hospital 
transfusion committees. 
The results were reported to the hospital transfusion 
committee. Informative and up-to-date material on trans-
fusional adequacy was prepared and is intended to be 
delivered to the pediatricians of the service, also available 
on the hospital’s computers for consultation. Training 
for pediatricians who make RBC prescriptions at our 
institution was also proposed. 
The strengths of this study include the number of 
transfusions analyzed, the analysis of requests made by 
pediatricians alone, a small percentage of loss (6.5%) and 
the availability of an official guide that has been con-
tinually updated to compare the results obtained. 
Regarding the limitations, the retrospective design, 
a lack of more detailed data on the clinical characteristics 
of the patients and the absence of a control between pre-
scribed vs. infused volume can be cited. 
conclusion
The results obtained in our study show that transfusion 
of RBC concentrates was more adequate when clinical 
status was taken into account. Also, there was a tendency 
to prescribe high volumes and subtypes of erythrocytes 
that cannot be justified according to current protocols.
Improving teaching of hemotherapy at medical un-
dergraduate and residency levels as well as the implemen-
tation of a continuing education project for pediatricians 
who work with critically ill children are crucial.
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resuMo
Avaliação da prescrição de concentrados de hemácias na 
faixa etária pediátrica
Objetivo: Verificar a adequação na prescrição de concen-
trado de hemácias (CH) por pediatras em diferentes se-
tores de um hospital pediátrico. 
Método: Realizou-se estudo retrospectivo onde avaliamos 
837/990 fichas de requisição de CH para crianças e ado-
lescentes (0 a 13 anos), preenchidas entre janeiro de 2007 
e abril de 2015 pelos médicos pediatras do pronto-socor-
ro (PS), da enfermaria e da unidade de terapia intensiva 
(UTI). Excluíram-se as transfusões realizadas em porta-
dores de anemia crônica, crianças com hemorragia aguda 
e requisições incompletas. 
Resultados: Gatilho, volume prescrito e subtipo de con-
centrado de hemácias foram adequados em 532 (65,3%), 
460 (58,8%) e 805 (96,2%) das transfusões, respectivamen-
te. Quando foi considerado o quadro clínico, a adequação 
foi maior em comparação à prescrição pelo valor isolado 
da hemoglobina (70,9% vs. 41%). A UTI teve o maior per-
centual de acerto no gatilho (343 [71,6%]; p<0,001) e o 
PS, no volume prescrito (119 [66,1%]; p=0,020). A inade-
quação mais comum, em relação ao volume, foi a prescri-
ção acima da recomendação (> 15 mL/kg, 309 [36,9%]). 
Foram solicitados 32 subtipos de CH e nenhum estava 
de acordo com as indicações atuais. 
Conclusão: Os resultados obtidos mostram que a trans-
fusão de CH aconteceu de forma mais adequada quando 
a situação clínica era levada em conta na solicitação. Hou-
ve uma tendência à prescrição de volumes elevados e de 
subtipos de hemácias não justificados segundo os proto-
colos atuais. É necessário melhorar o ensino de hemote-
rapia na graduação e residência médica.
Palavras-chave: Medicina Transfusional. Transfusão de 
Eritrócitos. Criança. Prescrições.
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